NATCO Pharma Balance Sheet Health
Financial Health criteria checks 6/6
NATCO Pharma has a total shareholder equity of ₹58.5B and total debt of ₹3.7B, which brings its debt-to-equity ratio to 6.3%. Its total assets and total liabilities are ₹69.1B and ₹10.5B respectively. NATCO Pharma's EBIT is ₹19.7B making its interest coverage ratio 97.5. It has cash and short-term investments of ₹18.5B.
Key information
6.3%
Debt to equity ratio
₹3.71b
Debt
| Interest coverage ratio | 97.5x |
| Cash | ₹18.49b |
| Equity | ₹58.53b |
| Total liabilities | ₹10.53b |
| Total assets | ₹69.06b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 524816's short term assets (₹40.2B) exceed its short term liabilities (₹9.7B).
Long Term Liabilities: 524816's short term assets (₹40.2B) exceed its long term liabilities (₹804.0M).
Debt to Equity History and Analysis
Debt Level: 524816 has more cash than its total debt.
Reducing Debt: 524816's debt to equity ratio has reduced from 11.1% to 6.3% over the past 5 years.
Debt Coverage: 524816's debt is well covered by operating cash flow (326.4%).
Interest Coverage: 524816's interest payments on its debt are well covered by EBIT (97.5x coverage).